We emphasise the significance of our study, as it compares the effectiveness of urinary [TIMP-2]•[IGFBP7], TIMP-2, IGFBP7, NGAL, and L-FABP in predicting CSA–AKI in Asian populations and investigates the optimal timing for measuring these biomarkers. This evidence concerns the gene FABP1 and acute kidney injury.